Barijak Tablet

About this Medicine

Barijak Tablet is used in combination with Remdesivir for the treatment of coronavirus disease (COVID-19) in hospitalized adults. Barijak Tablet may be prescribed by itself or in combination with another drug. The tablets can be taken with or without food, and it’s best to take them at the same time each day. Your dose will depend on your condition and what other medicines you’re taking. You should use it as your doctor tells you to. Don’t stop taking this medicine unless your doctor tells you to because your condition could get worse.The most common side effects of Barijak Tablet include throat and nose infections, nausea, and viral infection. You may also get cold sores, feel sick, or have symptoms of a cold like stuffy nose, sneezing, and sore throat. There are other less common side effects, some serious, including blood clots and tears in the stomach or intestine wall. These need urgent medical attention. If you have any worries about side effects, talk to your doctor.You may need blood tests before you’re given this medicine, and you shouldn’t start taking it if you have any infection. Make sure you talk to your doctor before beginning treatment if you have, or have ever had, tuberculosis, shingles, kidney or liver disease, hepatitis B or C, or blood clots in your legs or lungs. Barijak Tablet can make you more likely to get infections or may worsen any current infections, so avoid contact with people who have things you might catch (such as chickenpox, measles, and flu). This medicine is not suitable for children under 18 years old, and you shouldn’t use it if you’re pregnant or breastfeeding unless your doctor feels the benefit is greater than the risk. Your doctor may need to examine you regularly.

How it Works

Barijak Tablet is a Janus kinase (JAK) inhibitor that inhibits the activity of selective JAK1 and JAK2 enzymes, which interfere with the JAK-STAT signaling pathway (a chain of protein-cell interactions, involved in processes such as immunity, cell division, cell death, and tumor formation).

Key Facts

Chemical Class :: Pyrrolo Pyrimidine Derivative|Habit Forming :: No|Therapeutic Class :: PAIN ANALGESICS|Action Class :: Janus kinase inhibitors

Safety Overview